122 related articles for article (PubMed ID: 34693253)
1. Variability in CKD Biomarker Studies: Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Kidney Disease Progression in the Chronic Kidney Disease in Children (CKiD) Study.
Abraham AG; Xu Y; Roem JL; Greenberg JH; Weidemann DK; Sabbisetti VS; Bonventre JV; Denburg M; Warady BA; Furth SL
Kidney Med; 2021; 3(5):712-721.e1. PubMed ID: 34693253
[TBL] [Abstract][Full Text] [Related]
2. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
[TBL] [Abstract][Full Text] [Related]
3. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
[TBL] [Abstract][Full Text] [Related]
4. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
Ng DK; Schwartz GJ; Warady BA; Furth SL; Muñoz A
Am J Kidney Dis; 2017 Sep; 70(3):397-405. PubMed ID: 28549535
[TBL] [Abstract][Full Text] [Related]
5. Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes.
Le D; Chen J; Shlipak MG; Ix JH; Sarnak MJ; Gutierrez OM; Schelling JR; Bonventre JV; Sabbisetti VS; Schrauben SJ; Coca SG; Kimmel PL; Vasan RS; Grams ME; Parikh C; Coresh J; Rebholz CM;
Kidney Med; 2023 Nov; 5(11):100719. PubMed ID: 37841418
[TBL] [Abstract][Full Text] [Related]
6. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
[TBL] [Abstract][Full Text] [Related]
7. Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.
Jhee JH; Nam BY; Lee CJ; Park JT; Han SH; Kang SW; Park S; Yoo TH
J Am Heart Assoc; 2021 Jan; 10(1):e017225. PubMed ID: 33325248
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and Hypertension.
Chen TK; Estrella MM; Appel LJ; Coresh J; Luo S; Reiser J; Obeid W; Parikh CR; Grams ME
Am J Kidney Dis; 2021 Jul; 78(1):75-84.e1. PubMed ID: 33388403
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.
Hayek SS; Ko YA; Awad M; Ahmed H; Gray B; Hosny KM; Aida H; Tracy MJ; Wei C; Sever S; Reiser J; Quyyumi AA
Kidney Int Rep; 2017 May; 2(3):425-432. PubMed ID: 29142970
[TBL] [Abstract][Full Text] [Related]
10. Plasma and Urine Biomarkers of CKD: A Review of Findings in the CKiD Study.
Sandokji I; Greenberg JH
Semin Nephrol; 2021 Sep; 41(5):416-426. PubMed ID: 34916002
[TBL] [Abstract][Full Text] [Related]
11. Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease.
Hayek SS; Landsittel DP; Wei C; Zeier M; Yu ASL; Torres VE; Roth S; Pao CS; Reiser J
J Am Soc Nephrol; 2019 Jul; 30(7):1305-1313. PubMed ID: 31171572
[TBL] [Abstract][Full Text] [Related]
12. What is the Role of Soluble Urokinase-Type Plasminogen Activator in Renal Disease?
Saleem MA
Nephron; 2018; 139(4):334-341. PubMed ID: 29909410
[TBL] [Abstract][Full Text] [Related]
13. Soluble Urokinase Receptor and Chronic Kidney Disease.
Hayek SS; Sever S; Ko YA; Trachtman H; Awad M; Wadhwani S; Altintas MM; Wei C; Hotton AL; French AL; Sperling LS; Lerakis S; Quyyumi AA; Reiser J
N Engl J Med; 2015 Nov; 373(20):1916-25. PubMed ID: 26539835
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.
Winnicki W; Sunder-Plassmann G; Sengölge G; Handisurya A; Herkner H; Kornauth C; Bielesz B; Wagner L; Kikić Ž; Pajenda S; Reiter T; Schairer B; Schmidt A
Sci Rep; 2019 Sep; 9(1):13783. PubMed ID: 31551522
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes.
Höbaus C; Ursli M; Yussef SM; Wrba T; Koppensteiner R; Schernthaner GH
Vasc Med; 2021 Feb; 26(1):11-17. PubMed ID: 33448911
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease.
Lopez-Silva C; Surapaneni A; Coresh J; Reiser J; Parikh CR; Obeid W; Grams ME; Chen TK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):350-360. PubMed ID: 35197258
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy.
Wu CZ; Chang LC; Lin YF; Hung YJ; Pei D; Chu NF; Chen JS
Clin Biochem; 2015 Dec; 48(18):1324-9. PubMed ID: 26162494
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
19. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
20. Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients.
Iversen E; Houlind MB; Kallemose T; Rasmussen LJH; Hornum M; Feldt-Rasmussen B; Hayek SS; Andersen O; Eugen-Olsen J
Front Cell Dev Biol; 2020; 8():339. PubMed ID: 32596235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
